Maravai LifeSciences Holdings Inc
NASDAQ:MRVI
Maravai LifeSciences Holdings Inc
Revenue
Maravai LifeSciences Holdings Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Maravai LifeSciences Holdings Inc
NASDAQ:MRVI
|
Revenue
$288.9m
|
CAGR 3-Years
1%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Revenue
$42.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
12%
|
CAGR 10-Years
13%
|
|
Danaher Corp
NYSE:DHR
|
Revenue
$43.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
21%
|
CAGR 10-Years
9%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Revenue
$3.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
Agilent Technologies Inc
NYSE:A
|
Revenue
$6.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Revenue
$15B
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
Maravai LifeSciences Holdings Inc
Revenue Breakdown
Breakdown by Geography
Maravai LifeSciences Holdings Inc
Total Revenue:
288.9m
USD
|
North America:
141.1m
USD
|
Asia Pacific:
97.4m
USD
|
Europe, The Middle East And Africa:
49.9m
USD
|
Latin And Central America:
527k
USD
|
Breakdown by Segments
Maravai LifeSciences Holdings Inc
Total Revenue:
288.9m
USD
|
Nucleic Acid Production:
224.8m
USD
|
Biologics Safety Testing:
64.2m
USD
|
See Also
What is Maravai LifeSciences Holdings Inc's Revenue?
Revenue
288.9m
USD
Based on the financial report for Dec 31, 2023, Maravai LifeSciences Holdings Inc's Revenue amounts to 288.9m USD.
What is Maravai LifeSciences Holdings Inc's Revenue growth rate?
Revenue CAGR 5Y
18%
Over the last year, the Revenue growth was -67%. The average annual Revenue growth rates for Maravai LifeSciences Holdings Inc have been 1% over the past three years , 18% over the past five years .